Clinical Trials Directory

Trials / Completed

CompletedNCT05201339

Effect of Head-neck Rotation on I-gel™ Insertion

Effect of Head-neck Rotation on the Success Rate At First Attempt of I-gel™ Insertion

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
172 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

According to previous studies, head and neck rotation reduces the tongue from being rolled back by gravity, which resulted in increasing patency of the upper airway. Therefore, the purpose of this study is to verify whether head and neck rotation increases the first attempt success rate of i-gel™.

Detailed description

I-gel™ insertion has been reported that the success rate of insertion on the first attempt is 78.5%. There may be several causes of insertion failure. Tongue folding is a major obstacle preventing appropriate i-gel™ placement. To solve this problem, the previous study has proven the efficacy of the rotational technical for I-gel™ insertion and reported a success rate of 97%. However, the rotation of i-gel™ in the oral cavity may be limited, and it may take some learning curve to get used to it. According to previous studies, head and neck rotation increases the cross-sectional area of the upper airway, which resulted in increasing patency of the upper airway. Therefore, the purpose of this study is to verify whether head and neck rotation increases the first attempt success rate of i-gel™.

Conditions

Interventions

TypeNameDescription
PROCEDUREStandard methodInsert I-gel™ according to the manufacturer's instruction. Take the sniffing position and gently move the i-gel™ along the hard palate to the soft palate and the posterior oropharynx.
PROCEDUREHean and Neck RotationAfter rotating the patient's head and neck to the left maximally, insert the i-gel™ from the right side of the tongue to the midline. When the tip reaches the soft palate and oropharynx positions, turn the head and neck back to the neutral position.

Timeline

Start date
2022-02-25
Primary completion
2023-06-02
Completion
2023-06-02
First posted
2022-01-21
Last updated
2024-10-03

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05201339. Inclusion in this directory is not an endorsement.